Santiment: The number of active addresses for Litecoin, Maker, and Lido on-chain is growing rapidly

Medical device service provider InfuSystems Holdings Inc announced that, due to a structural adjustment of its biomedical service contract portfolio, its annual operating revenue is expected to decrease to $7.1 million starting from fiscal year 2026.

Westlake Chemical Partners LP expects a significant increase in its coverage ratio by 2026 as production scale and sales volume expand.

According to data as of February 19, Xenia Hotels & Resorts Inc (stock code: XHR) expects its same-store revenue per available room (RevPAR) in the first quarter of this year to increase by approximately 4.6% compared to the same period in 2025.

Westlake Chemical Corp (stock code: WLK) recently stated clearly that by 2026, the company's top priority will be to fully achieve the goals set in its Pem Profitability Improvement Plan—reaching $600 million in EBITDA.